PT1235916E - Polinucleótidos isolados com um teor reduzido de unidades de controlo epigenético 5'cpg3' e suas utilizações - Google Patents

Polinucleótidos isolados com um teor reduzido de unidades de controlo epigenético 5'cpg3' e suas utilizações Download PDF

Info

Publication number
PT1235916E
PT1235916E PT00991199T PT00991199T PT1235916E PT 1235916 E PT1235916 E PT 1235916E PT 00991199 T PT00991199 T PT 00991199T PT 00991199 T PT00991199 T PT 00991199T PT 1235916 E PT1235916 E PT 1235916E
Authority
PT
Portugal
Prior art keywords
cpg3
epigenetic control
isolated polynucleotides
reduced content
motifs
Prior art date
Application number
PT00991199T
Other languages
English (en)
Inventor
Jean-Francois Nicolas
Isabelle Henry
Andre Choulika
Original Assignee
Centre Nat Rech Scient
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Pasteur Institut filed Critical Centre Nat Rech Scient
Publication of PT1235916E publication Critical patent/PT1235916E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT00991199T 1999-12-06 2000-12-06 Polinucleótidos isolados com um teor reduzido de unidades de controlo epigenético 5'cpg3' e suas utilizações PT1235916E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002291367A CA2291367A1 (en) 1999-12-06 1999-12-06 Genetic constructions having a reduced or an increased number of epigenetic control regions and methods of use thereof

Publications (1)

Publication Number Publication Date
PT1235916E true PT1235916E (pt) 2008-08-12

Family

ID=4164770

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00991199T PT1235916E (pt) 1999-12-06 2000-12-06 Polinucleótidos isolados com um teor reduzido de unidades de controlo epigenético 5'cpg3' e suas utilizações

Country Status (12)

Country Link
US (1) US20040097439A9 (pt)
EP (2) EP1235916B1 (pt)
JP (1) JP2003515344A (pt)
AT (1) ATE394494T1 (pt)
AU (1) AU3159501A (pt)
CA (1) CA2291367A1 (pt)
CY (1) CY1108240T1 (pt)
DE (1) DE60038813D1 (pt)
DK (1) DK1235916T3 (pt)
ES (1) ES2304998T3 (pt)
PT (1) PT1235916E (pt)
WO (1) WO2001040478A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821855B1 (fr) * 2001-03-09 2004-04-02 Cayla Genes synthetiques et plasmides bacteriens depourvus de cpg
WO2002099105A2 (en) * 2001-06-05 2002-12-12 Cellectis Methods for modifying the cpg content of polynucleotides
WO2006114834A1 (ja) * 2005-03-31 2006-11-02 Hokkaido Technology Licensing Office Co., Ltd. 点特異的な官能基導入ベクターの構築方法
ZA200800901B (en) 2005-07-14 2010-05-26 Takeda San Diego Inc Histone deacetylase inhibitors
JP5733976B2 (ja) 2007-03-30 2015-06-10 ザ・リサーチ・ファウンデーション・フォー・ザ・ステート・ユニヴァーシティー・オブ・ニュー・ヨーク ワクチンに有用な弱毒化ウイルス
US9734283B2 (en) * 2011-12-30 2017-08-15 Washington State University Genomic features associated with epigenetic control regions and transgenerational inheritance of epimutations
US20230310452A1 (en) * 2020-08-26 2023-10-05 Mdi Biological Laboratory Bromodomain and extra terminal domain (bet) inhibitor compositions and methods thereof for use as anti-aging agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583009A (en) * 1992-12-08 1996-12-10 University Of Washington Method of preparing recombinant proteins in transgenic animals containing metallothionein gene elements that bestow tissue-independent copy number-dependent, position-indepedent gene expression
DE69417918T2 (de) * 1993-11-30 2000-01-05 Univ Montreal Mcgill Dna methyltransferase inhibierung
WO1997011972A1 (en) * 1995-09-28 1997-04-03 The Trustees Of Columbia University In The City Of New York Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof
US5856462A (en) * 1996-09-10 1999-01-05 Hybridon Incorporated Oligonucleotides having modified CpG dinucleosides
DE69838294T2 (de) * 1997-05-20 2009-08-13 Ottawa Health Research Institute, Ottawa Verfahren zur Herstellung von Nukleinsäurekonstrukten
CA2389334A1 (en) * 1999-10-29 2001-05-10 The Hospital For Sick Children Methylation of unstable sequences

Also Published As

Publication number Publication date
EP2053127A3 (en) 2009-11-11
CY1108240T1 (el) 2014-02-12
ES2304998T3 (es) 2008-11-01
US20040097439A9 (en) 2004-05-20
CA2291367A1 (en) 2001-06-06
AU3159501A (en) 2001-06-12
WO2001040478A2 (en) 2001-06-07
EP2053127A2 (en) 2009-04-29
US20030100528A1 (en) 2003-05-29
EP1235916A2 (en) 2002-09-04
DK1235916T3 (da) 2008-08-25
JP2003515344A (ja) 2003-05-07
DE60038813D1 (de) 2008-06-19
WO2001040478A3 (en) 2002-05-10
EP1235916B1 (en) 2008-05-07
ATE394494T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
ATE232880T1 (de) Neue nucleotidanaloga
ATE541576T2 (de) 2'-o,4'-c-methylen bicyclonukleoside
CY1108240T1 (el) ΑΠΟΜΟΝΩΜΕΝΑ ΠΟΛΥΝΟΥΚΛΕΟΤΙΔΙΑ ΤΑ ΟΠΟΙΑ ΕΧΟΥΝ ΕΝΑ ΜΕΙΩΜΕΝΟ ΠΕΡΙΕΧΟΜΕΝΟ ΜΟΤΙΒΩΝ 5΄CpG3΄ ΕΠΙΓΕΝΕΤΙΚΟΥ ΕΛΕΓΧΟΥ ΚΑΙ ΟΙ ΧΡΗΣΕΙΣ ΤΟΥΣ
BR9815855A (pt) Genes e métodos para controle de nematóides em plantas
EP0977767A4 (en) AMINOOXY-MODIFIED OLIGONUCLEOTIDES
FI875082A0 (fi) Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner.
EP1034302A4 (en) DE NOVO OR "UNIVERSAL" SEQUENCING ARRAY
HK1022719A1 (en) Hamster ef-1 alpha transcriptional regulatory DNA
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
BR0003943A (pt) Sequências de nucleotìdeo que codificam para o gene thre e processo para a produção enzimática de l-treonina usando bactérias corineforma
AU5720498A (en) Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
EP3040423A3 (en) Microrna and uses thereof
WO1995014782A3 (en) A modified thermo resistant dna polymerase
AU2299999A (en) Dnas or genes participating in parkinson's disease
DE60042178D1 (de) Gene, welche für Flavon-Synthasen kodieren
WO1999028439A3 (fr) Erythrovirus et ses applications
HUP0101961A2 (hu) Az FSH-béta-gén módosítása homológ rekombinációval
AP2002002419A0 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
ATE310823T1 (de) Expressionssystem zur produktion von proteinen in pilzen
WO1998009633A3 (en) Pharmaceutical compositions
WO2003054181A3 (en) Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants
AU6659898A (en) Improved chimeric oligonucleotide vectors
WO2001030991A3 (en) Human narcolepsy gene
EP1724351A3 (en) Human Kallikrein-like genes
HK1084148A1 (en) Mn gene and protein